Bringing the Oncology Community Together

Head and Neck

OncLive TV - A Network of Your Peers

Dr. Cohen on mTOR Inhibition in Head and Neck Cancer

Dr. Burtness on 2 Types of Head and Neck Cancer

Dr. Vokes on Cetuximab for Head and Neck Cancer

Dr. Sherman Discusses the Vandetanib Trial

Dr. Mehra Discusses DNA Repair Enzymes

>>> More Head and Neck Videos

HPV Plays Growing Role in Evaluating Therapies

Researchers are dissecting new studies regarding targeted therapies as well as combined therapeutic approaches for HPV in the progression of head and neck cancers.

Oncology Live > Specialty Focus

Addition of Bevacizumab May Help in Nasopharyngeal Cancer

Researchers are reporting favorable early results with the addition of bevacizumab to conventional chemoradiation in patients with advanced nasopharyngeal cancer.

Oncology Live > Specialty Focus

HPV and the Rise of Head and Neck Cancers

Human papillomavirus is perhaps best known as the main cause of cervical cancer, but if recent trends continue, by 2020 HPV will cause more cases of oropharyngeal cancer each year than cervical cancer.

Oncology & Biotech News > Feature Article

Mouth Care Systems Alleviate Xerostomia After Radiotherapy

Radiotherapy often results in the loss of some salivary gland function, causing hyposalivation and xerostomia.

Oncology & Biotech News > News

Oral HPV Infections More Prevalent in Men

Approximately 7% of Americans carry the human papillomavirus (HPV) in their oral cavities, and men are 3 times more likely to carry the virus than women.

> Web Exclusives

Minimally Invasive Surgeries Retain Place in Treatment Plan

In an era when advances in chemoradiation and targeted therapies have revolutionized treatment in head and neck oncology patients, it's possible that treating physicians might not know where surgery fits into the regimen.

Oncology Live > Specialty Focus

>>> Click here for more articles